1 Min Read
March 5 (Reuters) - Biofrontera AG:
* PTA-ADHOC: BIOFRONTERA AG: EUROPEAN COMMISSION APPROVES USE OF AMELUZ IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.